SUPERANNUATION fund First State Super has wiped from its investment portfolios all companies involved in the manufacture of tobacco products, in a move welcomed by cancer specialists.
Chief executive Michael Dwyer said the decision to exclude the cigarette and tobacco companies from its entire investment portfolio followed strong feedback from the health industry, which represents about 40 per cent of the fund's 770,000 members.
"In reaching its decision the trustee board had been particularly mindful of its many members who work in the health sector, especially members from the Peter MacCallum Cancer Centre in Melbourne," Mr Dwyer said yesterday.
"Our decision reflects both the strong views expressed by our employers and members and our support for government initiatives to minimise tobacco consumption."
He said a review of each fund's investment strategies showed excluding tobacco companies would not compromise returns.
"Our analysis shows there will be inconsequential financial impact from this decision for members' investment returns.
"It adds to the decision that the exclusion of direct tobacco investments is unquestionably the right thing to do," he said.
Cancer clinicians and researchers at Melbourne's Peter MacCallum Cancer Centre welcomed the announcement.
Health professionals, including specialists at Peter Mac, have urged all superannuation companies to exclude tobacco-related corporations from their default investment options.
Peter Mac radiation oncologist Dr Bronwyn King applauded First State Super for "breaking the mould".
The chairman of Peter Mac's Lung Service, Professor David Ball, said the move by First State "should be replicated across the superannuation industry".